Literature DB >> 26206917

IMMUNOLOGY. Moving CTLA-4 from the trash to recycling.

David M Sansom1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26206917     DOI： 10.1126/science.aac7888

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

1.  LRBA is essential for urinary concentration and body water homeostasis.

Authors:  Yu Hara; Fumiaki Ando; Daisuke Oikawa; Koichiro Ichimura; Hideki Yanagawa; Yuriko Sakamaki; Azuma Nanamatsu; Tamami Fujiki; Shuichi Mori; Soichiro Suzuki; Naofumi Yui; Shintaro Mandai; Koichiro Susa; Takayasu Mori; Eisei Sohara; Tatemitsu Rai; Mikiko Takahashi; Sei Sasaki; Hiroyuki Kagechika; Fuminori Tokunaga; Shinichi Uchida
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-21       Impact factor: 12.779

2.  Characterization of CTLA4 Trafficking and Implications for Its Function.

Authors:  Sahamoddin Khailaie; Behzad Rowshanravan; Philippe A Robert; Erin Waters; Neil Halliday; Jesus David Badillo Herrera; Lucy S K Walker; David M Sansom; Michael Meyer-Hermann
Journal:  Biophys J       Date:  2018-08-23       Impact factor: 4.033

3.  Two male siblings with a novel LRBA mutation presenting with different findings of IPEX syndrome.

Authors:  Sanem Eren Akarcan; Neslihan Edeer Karaca; Guzide Aksu; Ayca Aykut; Deniz Yilmaz Karapinar; Funda Cetin; Yesim Aydinok; Elif Azarsiz; Eleonora Gambineri; Ozgur Cogulu; Ezgi Ulusoy Severcan; Hudaver Alper; Necil Kutukculer
Journal:  JMM Case Rep       Date:  2018-10-15

4.  Case Report: Refractory Autoimmune Gastritis Responsive to Abatacept in LRBA Deficiency.

Authors:  Valentina Boz; Erica Valencic; Martina Girardelli; Alessia Pin; Laura Gàmez-Diaz; Alberto Tommasini; Sara Lega; Matteo Bramuzzo
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

5.  Continuous Modeling of T CD4 Lymphocyte Activation and Function.

Authors:  David Martínez-Méndez; Luis Mendoza; Carlos Villarreal; Leonor Huerta
Journal:  Front Immunol       Date:  2021-11-05       Impact factor: 7.561

6.  Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.

Authors:  Alan Kennedy; Erin Waters; Behzad Rowshanravan; Claudia Hinze; Cayman Williams; Daniel Janman; Thomas A Fox; Claire Booth; Anne M Pesenacker; Neil Halliday; Blagoje Soskic; Satdip Kaur; Omar S Qureshi; Emma C Morris; Shinji Ikemizu; Christopher Paluch; Jiandong Huo; Simon J Davis; Emmanuel Boucrot; Lucy S K Walker; David M Sansom
Journal:  Nat Immunol       Date:  2022-08-23       Impact factor: 31.250

7.  Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations.

Authors:  Tie Zheng Hou; Nisha Verma; Jennifer Wanders; Alan Kennedy; Blagoje Soskic; Daniel Janman; Neil Halliday; Behzad Rowshanravan; Austen Worth; Waseem Qasim; Helen Baxendale; Hans Stauss; Suranjith Seneviratne; Olaf Neth; Peter Olbrich; Sophie Hambleton; Peter D Arkwright; Siobhan O Burns; Lucy S K Walker; David M Sansom
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

Review 8.  Immune based therapy for melanoma.

Authors:  Robert Ancuceanu; Monica Neagu
Journal:  Indian J Med Res       Date:  2016-02       Impact factor: 2.375

9.  Association between CTLA-4 gene polymorphism and risk of rheumatoid arthritis: a meta-analysis.

Authors:  Chuankun Zhou; Shutao Gao; Xi Yuan; Zixing Shu; Song Li; Xuying Sun; Jun Xiao; Hui Liu
Journal:  Aging (Albany NY)       Date:  2021-08-02       Impact factor: 5.682
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.